Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nicola Ferrari

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Dendritic Cells

Acute Lymphoblastic Leukemia

Immune Response

Top Venues

Science advances

Nature communications

Astex Pharmaceuticals

Università degli Studi di Bologna (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Astex Pharmaceuticals Sep 11o 2017

United Kingdom

Research Associate :: Translational R&D

Education History

Università degli Studi di Bologna

Italy

MSC

Publications

Remi Samain, Oscar Maiques, Joanne Monger, Hoyin Lam, Juliana Candido, Samantha George, Nicola Ferrari, Leonie KohIhammer, Sophia Lunetto, Adrian Varela, Jose L Orgaz, Felip Vilardell, Jorge Juan Olsina, Xavier M Guiu, Debashis Sarker, Adrian Biddle, Frances R Balkwill, Jim Eyles, Robert W Wilkinson, Hemant Mahendrakumar Kocher, Fernando Calvo, Claire M Wells, Victoria Sanz-Moreno
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Science advances 9 (42) (2023)
Nicola Ferrari, George Ward, Christina Gewinner, Matthew P Davis, Simone Jueliger, Harpreet Saini, Joanne Munck, Tomoko Smyth, Roberta Ferraldeschi, Harold Keer, John Lyons, Martin J Sims
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma. Blood advances 5 (20) (2021)
Nicola Ferrari, Romana Ranftl, Ievgeniia Chicherova, Neil D Slaven, Emad Moeendarbary, Aaron J Farrugia, Maxine Lam, Maria Semiannikova, Marie C W Westergaard, Julia Tchou, Luca Magnani, Fernando Calvo
Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. Nature communications 10 (1) (2019)